U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07534709) titled 'Suzetrigine for Opioid-Free Recovery After Cesarean Delivery' on April 07.
Brief Summary: The goal of this clinical trial is to determine whether suzetrigine increases the proportion of patients who remain completely opioid-free from completion of surgery through 72 hours after cesarean delivery.
The main question it aims to answer is:
Does adjunctive suzetrigine, when added to a standardized multimodal postoperative analgesic regimen, increase the proportion of patients who remain opioid-free during the first 72 hours after cesarean delivery?
Researchers will compare suzetrigine to a placebo (a look-alike substance that contain...